Crossmark

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

Crossref DOI link: https://doi.org/10.1186/s12933-017-0564-0

Published Online: 2017-07-06

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shigiyama, Fumika

Kumashiro, Naoki http://orcid.org/0000-0002-5432-3599
Miyagi, Masahiko

Ikehara, Kayoko

Kanda, Eiichiro

Uchino, Hiroshi

Hirose, Takahisa
Clinical Trials ^BETA

Clinical trials referenced in this document:

umin000018754 at UMIN Japan

Documents that mention this clinical trial

Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study
https://doi.org/10.1186/s12933-017-0564-0
Funding

Funding for this research was provided by:

Astrazeneca Japan K.K.

ONO PHARMACEUTICAL CO., LTD
License Information

Text and Data Mining valid from 2017-07-06

Version of Record valid from 2017-07-06
More Information

Article History

Received: 6 May 2017

Accepted: 20 June 2017

First Online: 6 July 2017

Document is current

Any future updates will be listed below